The prognostic value of early measures of the ventilatory ratio in the ARDS ROSE trial

By rosaguerrero • September 30, 2022

Monteiro ACC, Vangala S, Wick KD, Delucchi KL, Siegel ER, Thompson BT, Liu KD, Sapru A, Sinha P, Matthay MA; NHLBI PETAL Network. The prognostic value of early measures of the ventilatory ratio in the ARDS ROSE trial. Crit Care. 2022 Sep 29;26(1):297. doi: 10.1186/s13054-022-04179-7. PMID: 36175982.

Tags: APACHE-III, ARDS, Neuromuscular blockade, Publications, Pulmonary, Critical Care & Sleep Medicine, ROSE trial, Ventilatory ratio

Related Posts

Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer

Weiner AB, Agrawal R, Wang NK, Sonni I, Li EV, Arbet J, Zhang JJH, Proudfoot JA, Hong BH, Davicioni E, Kane N, Valle LF, Kishan[...]

A survey of cystic fibrosis physicians’ views on lung transplant referral in the era of elexacaftor/tezacaftor/ivacaftor

Burdis N, Milinic T, Bartlett LE, Goss L, Tallarico E, Boyle A, Thaxton A, Turner GA, Benvenuto LJ, Faro A, Goss CH, Kapnadak SG, Ramos[...]

In-Hospital Mortality and Treatment in Patients With Acute Coronary Syndrome With and Without Standard Modifiable Cardiovascular Risk Factors: Findings From the CCC-ACS Project

Gong W, Yan Y, Liu J, Wang X, Zheng W, Que B, Ai H, Smith SC Jr, Fonarow GC, Morgan L, Zhao D, Ma C,[...]